NCT07506031

Brief Summary

This prospective study aims to evaluate the role of shear wave elastography (SWE) as a non-invasive and radiation-free tool for predicting the success of extracorporeal shock wave lithotripsy (ESWL) in pediatric patients with renal stones. Currently, computed tomography (CT)-derived Hounsfield units (HU) are used to estimate stone hardness; however, repeated radiation exposure is a concern in children. SWE may provide an alternative method by assessing stone stiffness using ultrasound. Pediatric patients under 18 years with renal stones (6-20 mm) scheduled for ESWL will be included. SWE measurements will be performed prior to treatment, and patients will be followed for 3 months to assess treatment outcomes. The primary outcome is ESWL success, while secondary outcomes include correlation between SWE and HU, number of ESWL sessions required, prediction of stone composition, and assessment of the relationship between SWE measurements and stone composition. This study seeks to determine whether SWE can serve as a reliable predictor of ESWL outcomes, correlate with stone composition, and reduce the need for radiation-based imaging in children.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for all trials

Timeline
1mo left

Started Dec 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Dec 2025Jun 2026

Study Start

First participant enrolled

December 2, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 24, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 1, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

April 1, 2026

Status Verified

March 1, 2026

Enrollment Period

5 months

First QC Date

March 24, 2026

Last Update Submit

March 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • ESWL Success Rate

    Treatment success defined as absence of stone fragments or presence of clinically insignificant residual fragments ≤2 mm on imaging, without symptoms, obstruction, or urinary tract infection.

    3 months with maximum 3 sessions ESWL

Secondary Outcomes (1)

  • Secondary Outcomes Related to SWE and ESWL

    Up to 3 months after ESWL

Study Arms (1)

Pediatric Patients Undergoing ESWL

Pediatric patients (\<18 years) with renal stones (6-20 mm) undergoing extracorporeal shock wave lithotripsy (ESWL). All patients will undergo baseline shear wave elastography (SWE) assessment prior to treatment. Patients will be followed for 3 months to evaluate ESWL success and its correlation with SWE measurements, Hounsfield units (HU), and stone composition.

Eligibility Criteria

Age1 Year - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pediatric patients under 18 years of age diagnosed with renal stones measuring 6-20 mm and scheduled for extracorporeal shock wave lithotripsy (ESWL). Patients will be recruited from the outpatient clinic and followed for 3 months. Proper history, examination and basic laboratory investigations (CBC, coagulation profile, kidney and Liver functions, urine analysis and urine culture and sensitivity) will be performed for all participants. Low dose CTUT will be performed as usual for all patient to record stone location, size (maximum longitudinal and transverse dimensions), and HU. Renal stone elastography values will be measured by a single radiologist using grayscale renal US and SWE. SWE measurements will be performed once prior to ESWL. A Philips EPİQ7 system (Philips Medical Systems, Bothell, WA) with a 1-5-MHz abdominal probe will be used for the procedure.

You may qualify if:

  • Single Renal stones measured 6- 20 mm in maximal dimension.
  • ESWL will be planned as the first line of treatment.

You may not qualify if:

  • Patients with internal ureteral stent.
  • ureteral stones.
  • abnormal renal anatomies (pelvic kidney, horseshoe kidney, and rotational anomaly).
  • active UTI at time of ESWL.
  • coagulopathy .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

faculty of medicine Beni Suef university hospital

Banī Suwayf, 62511, Egypt

RECRUITING

Central Study Contacts

Mahmoud Abdallah Mahmoud, MD of urology

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of urology faculty of medicine Beni Suef university

Study Record Dates

First Submitted

March 24, 2026

First Posted

April 1, 2026

Study Start

December 2, 2025

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

April 1, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations